Skip to main content

InvestorNewsBreaks – SenesTech Inc. (NASDAQ: SNES) Announces Global Partnership in Expansion of Evolve(TM) Soft Bait to Open-Field Agriculture Applications

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal-pest populations, has expanded the use of its innovative soft bait fertility control solution, Evolve(TM), into the open-field agriculture market. According to the announcement, this expansion includes a partnership with a global leader in irrigation solutions for sustainable agriculture; the first use of Evolve in the planned expansion will be at a California dairy and almond grower. Evolve focuses on the rapid reproduction of rats by reducing or eliminating the fertility of rats. Highly appealing to rats, Evolve is easy to deploy and can be used in many different environments; the product is also priced competitively to rodenticide alternatives. “Open-field agriculture presents a unique challenge to rodent pest control,” said SenesTech president and CEO Joel Fruendt in the press release. “Poisons cannot be broadcast, and trapping is expensive and of limited efficacy. The Evolve soft bait, with its minimum risk, its reasonable cost, and its proven efficacy, provides a new tool for this widespread market. We are partnering with one of the global leaders in irrigation solutions, with a commitment to sustainability, and they have selected one of their preferred customers for the initial deployment, a diary and almond producer. Their stated goal is to ultimately expand the offering of Evolve to their customers across the globe as they learn more about Evolve’s potential.”

 To view the full press release, visit

About SenesTech Inc.

SenesTech is committed to improving the health of the world by humanely managing animal-pest populations through fertility control. The company is expert in fertility control to manage animal-pest populations. SenesTech invented ContraPest, the only U.S. EPA-registered contraceptive for male and female rats, and Evolve, an EPA-designated minimum-risk contraceptive currently offered for rats. ContraPest and Evolve fit seamlessly into all integrated pest-management programs, significantly improving the overall goal of effective pest management. The company strives for clean cities, efficient businesses and happy households by providing a product designed to be humane, effective and sustainable. For more information about the company, please visit

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published:

Los Angeles, CA
310.299.1717 Office

InvestorWire is powered by IBN

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.